Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01166893
Other study ID # 20097322
Secondary ID R01GM108634
Status Recruiting
Phase
First received
Last updated
Start date March 2010
Est. completion date February 2026

Study information

Verified date December 2023
Source University of California, Irvine
Contact Gordon Kennedy, PhD
Phone 949-824-4713
Email gordon.kennedy@uci.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

According to the National Burn Repository 2007, the most common type of burn injury is a partial thickness burns. The current standard of care for partial thickness burns is two weeks of topical therapy and wound care. Burns that do not heal within two weeks undergo surgical excision and skin grafting.


Description:

Researcher can use the combination of Modulated Imaging and Laser Speckle Imaging can be used as an adjuvant to standard clinical evaluation to gauge burn wound and severity of infection. Researcher can image the burn wounds of and compare with current standard of care, clinical exam, and can use the outcomes information in terms of time to healing and treatment Modulating Imaging is a noninvasive optical modality measure the metabolic functions of the burn wound. Laser Speckle Imaging is a noninvasive optical modality can measure blood flow of burn wound.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date February 2026
Est. primary completion date February 2026
Accepts healthy volunteers No
Gender All
Age group 1 Minute and older
Eligibility Inclusion Criteria: 1. Male / female all age 2. Subjects is an inpatient or out patient with burn wound Exclusion Criteria: 1. Subjects cannot lied flat and still for the duration of the imaging 2. Subjects pregnant.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Modulated Imaging and Laser Speckle Imaging
wound healing

Locations

Country Name City State
United States UCIMC Orange California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Irvine National Institute of General Medical Sciences (NIGMS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Noninvasive burn wound severity assessment Noninvasive burn wound severity assessment using noncontact optical device 1 day